Immune Function Monitoring and Immunotherapy in Sepsis (IMITS)

Sun Yat-sen University

Status: Unknown

Conditions: Septic Shock; Sepsis

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT04903405

IMITS

Details and patient eligibility

About

At present, the clinical studies of various anti-inflammatory drugs and immune-enhancing drugs show that immunotherapy will bring new hope for the treatment of sepsis. In order to further understand the current status of immunotherapy in China, this study aims to understand the current status and standardization of the use of sepsis immunosurveillance and immunotherapy in hospitals through a cross-sectional survey.

Enrollment: 5,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with sepsis or septic shock according to Sepsis 3.0

Exclusion criteria

• None

Trial design

5,000 participants in 1 patient group

Sepsis

Treatment:

Other: No intervention